PB1760: AZACITIDINE AS TREATMENT OF KMT2A INFANT ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE. (23rd June 2022) - Giagnuolo, G.; De Matteo, A.; Stellato, P.; Petruzziello, F.; Cuccurullo, R.; Beneduce, G.; Cacace, F.; Tambaro, F. P.; Parasole, R.; Menna, G.